Edit |   |
---|---|
Antigenic Specificity | IL17A, Human (Ixekizumab biosimilar) |
Clone | Ixekizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | WB, IP, IF, FuncS, FCM, Neut, ELISA |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human IL17A Recombinant Antibody (Ixekizumab). Ixekizumab, sold under the brand name Taltz, is an injectable medication for the treatment of autoimmune diseases. Chemically, it is a form of a humanized monoclonal antibody.[5] The substance acts by binding interleukin 17A and neutralizing it, reducing inflammation. |
Immunogen | n/a |
Other Names | Anti-IL17A Recombinant Antibody, Research Grade Ixekizumab, Anti-Human IL17A Recombinant Antibody(Ixekizumab), LY2439821, Ixekizumab, Antibody Drug Analogues, Monoclonal Antibody, YR1008, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1143503-69-8 |
Catalog # | YR1008 |
Price | please inquire |
Order / More Info | IL17A, Human (Ixekizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |